Pulmonx Corporation
A maker of minimally invasive devices for people with severe emphysema and COPD, Pulmonx built its business around the Zephyr Endobronchial Valve, a tiny one-way implant placed through a bronchoscope to let trapped air escape from diseased lung lobes so healthier tissue can work. The company was founded in California in 1995 by Dr. Rodney Perkins. Its flagship product takes its name from the Greek word for a gentle west wind — a nod to helping patients breathe more easily.
Granted 2.8K · Bought 13.2K
Granted 1.59M · Sold 757.0K
Sold 4.50M
Granted 1.40M · Sold 36.1K
Granted 505.5K · Sold 157.8K
Granted 494.0K · Sold 113.5K
Granted 387.0K · Bought 14.2K · Sold 47.3K
Granted 175.0K · Sold 25.0K
Granted 233.9K · Sold 30.4K
Granted 113.4K · Bought 26.3K
Granted 110.6K · Bought 26.3K
Granted 113.4K · Bought 43.8K · Sold 23.3K
Granted 110.6K · Bought 5.4K · Sold 8.0K
Granted 115.2K
Granted 113.4K
Granted 36.0K · Sold 942
Granted 22.8K · Bought 1.7K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Ferrari Richard MDirector · 8 transactions | — | 2.49Mas of Jun 2021 | 2.8K | 13.2K | — |
| French Glendon E. IIIPresident and CEO, Director · 91 transactions | — | 2.10M | 1.59M | — | 757.0K |
| Boston Scientific Corp10% owner · 10 transactions | — | 1.49Mas of Jul 2021 | — | — | 4.50M |
| Sung DerrickCOO and CFO · 33 transactions | — | 1.34M | 1.40M | — | 36.1K |
| Lindstrand StaffanDirector · 6 transactions | — | 1.13Mas of Oct 2020 | — | — | — |
| Rose Geoffrey BeranCHIEF COMMERCIAL OFFICER · 97 transactions | — | 460.0K | 505.5K | — | 157.8K |
| Lehman David AaronGENERAL COUNSEL · 64 transactions | — | 384.6K | 494.0K | — | 113.5K |
| Williamson Steven S.PRESIDENT AND CEO, Director · 8 transactions | — | 363.5K | 387.0K | 14.2K | 47.3K |
| Radhakrishnan SrikanthChief Science &Techn. Officer · 9 transactions | — | 340.9K | 175.0K | — | 25.0K |
| Joshi MehulChief Financial Officer & PAO · 7 transactions | — | 208.5K | 233.9K | — | 30.4K |
| Mead Dana G Jr.Director · 10 transactions | — | 143.8K | 113.4K | 26.3K | — |
| Melenikiotou GeorgiaDirector · 6 transactions | — | 139.7K | 110.6K | 26.3K | — |
| Florin Daniel PDirector · 11 transactions | — | 133.9K | 113.4K | 43.8K | 23.3K |
| Ferrari RichardDirector · 8 transactions | — | 127.0K | 110.6K | 5.4K | 8.0K |
| Sullivan TiffanyDirector · 6 transactions | — | 115.2K | 115.2K | — | — |
| Burns Thomas WilliamDirector · 6 transactions | — | 113.4K | 113.4K | — | — |
| McKune JohnINTERIM CFO · 5 transactions | — | 76.2Kas of Mar 2024 | 36.0K | — | 942 |
| Lynch Alissa HsuDirector · 4 transactions | — | 24.5Kas of Jun 2023 | 22.8K | 1.7K | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: -5.57M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.